Vipan Dhall

Title: Vipan Dhall: Innovator in Pharmaceutical Formulations

Introduction

Vipan Dhall is a notable inventor based in Brampton, Canada. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative drug delivery systems. His work focuses on improving the pharmacokinetic profiles of medications, which can lead to enhanced therapeutic outcomes.

Latest Patents

Vipan Dhall holds 1 patent for his invention related to pharmaceutical formulations. His patent addresses the pharmacokinetic profile of the SGLT2 inhibitor bexagliflozin. By formulating it as an extended-release tablet, he has demonstrated that it is possible to achieve a lower peak plasma concentration while maintaining therapeutic levels for an extended period. This advancement allows for the administration of lower doses without compromising the pharmacological effect.

Career Highlights

Vipan Dhall is currently associated with Theracosbio, LLC, where he continues to innovate in the pharmaceutical sector. His expertise in drug formulation has positioned him as a valuable asset in the company, contributing to the development of effective therapeutic solutions.

Collaborations

Throughout his career, Vipan has collaborated with talented professionals, including Feng Wang and Ankit Shrivastava. These collaborations have fostered a creative environment that encourages the exchange of ideas and the advancement of pharmaceutical technologies.

Conclusion

Vipan Dhall's contributions to pharmaceutical formulations exemplify the impact of innovative thinking in medicine. His work not only enhances drug delivery systems but also improves patient outcomes through more effective treatment options.